WO2011038149A3 - Méthodes de traitement d'une inflammation - Google Patents
Méthodes de traitement d'une inflammation Download PDFInfo
- Publication number
- WO2011038149A3 WO2011038149A3 PCT/US2010/050047 US2010050047W WO2011038149A3 WO 2011038149 A3 WO2011038149 A3 WO 2011038149A3 US 2010050047 W US2010050047 W US 2010050047W WO 2011038149 A3 WO2011038149 A3 WO 2011038149A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- mif
- treating inflammation
- cxcr2
- cxcr4
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 102100028989 C-X-C chemokine receptor type 2 Human genes 0.000 abstract 2
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 abstract 2
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 abstract 2
- 108010018951 Interleukin-8B Receptors Proteins 0.000 abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR112012006468A BR112012006468A2 (pt) | 2009-09-23 | 2010-09-23 | métodos de tratamento de inflamação |
CN2010800526286A CN102725311A (zh) | 2009-09-23 | 2010-09-23 | 治疗发炎的方法 |
AU2010298249A AU2010298249A1 (en) | 2009-09-23 | 2010-09-23 | Methods of treating inflammation |
MX2012003514A MX2012003514A (es) | 2009-09-23 | 2010-09-23 | Metodos para tratamiento de inflamaciones. |
IN2423DEN2012 IN2012DN02423A (fr) | 2009-09-23 | 2010-09-23 | |
EP10819481.2A EP2480579A4 (fr) | 2009-09-23 | 2010-09-23 | Méthodes de traitement d'une inflammation |
CA2773978A CA2773978A1 (fr) | 2009-09-23 | 2010-09-23 | Methodes de traitement d'une inflammation |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24521409P | 2009-09-23 | 2009-09-23 | |
US61/245,214 | 2009-09-23 | ||
US31903910P | 2010-03-30 | 2010-03-30 | |
US61/319,039 | 2010-03-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011038149A2 WO2011038149A2 (fr) | 2011-03-31 |
WO2011038149A3 true WO2011038149A3 (fr) | 2011-10-27 |
Family
ID=43796491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/050047 WO2011038149A2 (fr) | 2009-09-23 | 2010-09-23 | Méthodes de traitement d'une inflammation |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2480579A4 (fr) |
KR (1) | KR20120105429A (fr) |
CN (1) | CN102725311A (fr) |
AU (1) | AU2010298249A1 (fr) |
BR (1) | BR112012006468A2 (fr) |
CA (1) | CA2773978A1 (fr) |
IN (1) | IN2012DN02423A (fr) |
MX (1) | MX2012003514A (fr) |
WO (1) | WO2011038149A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013010955A1 (fr) | 2011-07-15 | 2013-01-24 | Morphosys Ag | Anticorps à réactions croisées anti-facteur inhibiteur de la migration des macrophages (mif) et anti-d-dopachrome tautomérase (d-dt) |
US9328174B2 (en) * | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
AU2013262397B2 (en) * | 2012-05-17 | 2017-07-27 | Anji Pharmaceuticals Inc. | Methods and uses for proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors |
TW201605886A (zh) * | 2013-11-14 | 2016-02-16 | 巴克斯特保健公司 | 作爲治療標靶的mif |
CA3017345A1 (fr) | 2016-03-11 | 2017-09-14 | Ardea Biosciences, Inc. | Inhibiteurs du cxcr-2 permettant de traiter des troubles associes a une arthropathie cristalline |
AU2019282132A1 (en) | 2018-06-05 | 2020-12-17 | Anji Pharmaceuticals Inc. | Compositions and methods for treating pancreatitis |
US11573228B2 (en) * | 2018-12-26 | 2023-02-07 | Colgate-Palmolive Company | Biomarkers of neutrophil deregulation as diagnostic for gingivitis |
JP2023517616A (ja) * | 2020-03-11 | 2023-04-26 | バイオラインアールエックス・リミテッド | 急性呼吸窮迫症候群およびウイルス感染の治療用のcxcr4阻害剤 |
WO2021219495A1 (fr) * | 2020-04-28 | 2021-11-04 | Dalcor Pharma Uk Ltd., Leatherhead, Zug Branch | Méthodes de traitement ou de prévention d'une infection virale ou d'inhibition de la réplication virale |
CN112656934A (zh) * | 2021-01-22 | 2021-04-16 | 深圳市图微安创科技开发有限公司 | 多肽at03在治疗原发性胆汁性胆管炎药物中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009149A1 (en) * | 2002-02-27 | 2004-01-15 | Altman John D. | Multimeric binding complexes |
US20040115193A1 (en) * | 2002-03-01 | 2004-06-17 | Immunomedics, Inc. | Internalizing anti-CD-74 antibodies and methods of use |
US20050176039A1 (en) * | 2003-12-30 | 2005-08-11 | Siegler Katherine M. | Macrophage migration inhibitory factor (MIF) as marker for urological inflammatory disease |
EP1724286A1 (fr) * | 2005-05-17 | 2006-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Variante du polypeptide CD44, polynucléotides les codant, anticorps le liant, et procédé d'utilisation pour le diagnostic et le traitement des maladies inflammatoires |
US20070071675A1 (en) * | 2005-08-19 | 2007-03-29 | Chengbin Wu | Dual variable domain immunoglobulin and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0910259A2 (pt) * | 2008-03-20 | 2015-12-01 | Carolus Therapeutics Inc | métodos de tratamento de inflamação |
WO2010056910A2 (fr) * | 2008-11-12 | 2010-05-20 | Carolus Therapeutics, Inc. | Procedes de traitement de troubles cardio-vasculaires |
-
2010
- 2010-09-23 AU AU2010298249A patent/AU2010298249A1/en not_active Abandoned
- 2010-09-23 WO PCT/US2010/050047 patent/WO2011038149A2/fr active Application Filing
- 2010-09-23 EP EP10819481.2A patent/EP2480579A4/fr not_active Withdrawn
- 2010-09-23 IN IN2423DEN2012 patent/IN2012DN02423A/en unknown
- 2010-09-23 CA CA2773978A patent/CA2773978A1/fr not_active Abandoned
- 2010-09-23 MX MX2012003514A patent/MX2012003514A/es unknown
- 2010-09-23 KR KR1020127010455A patent/KR20120105429A/ko not_active Application Discontinuation
- 2010-09-23 CN CN2010800526286A patent/CN102725311A/zh active Pending
- 2010-09-23 BR BR112012006468A patent/BR112012006468A2/pt not_active IP Right Cessation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040009149A1 (en) * | 2002-02-27 | 2004-01-15 | Altman John D. | Multimeric binding complexes |
US20040115193A1 (en) * | 2002-03-01 | 2004-06-17 | Immunomedics, Inc. | Internalizing anti-CD-74 antibodies and methods of use |
US20050176039A1 (en) * | 2003-12-30 | 2005-08-11 | Siegler Katherine M. | Macrophage migration inhibitory factor (MIF) as marker for urological inflammatory disease |
EP1724286A1 (fr) * | 2005-05-17 | 2006-11-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Variante du polypeptide CD44, polynucléotides les codant, anticorps le liant, et procédé d'utilisation pour le diagnostic et le traitement des maladies inflammatoires |
US20070071675A1 (en) * | 2005-08-19 | 2007-03-29 | Chengbin Wu | Dual variable domain immunoglobulin and uses thereof |
Non-Patent Citations (2)
Title |
---|
See also references of EP2480579A4 * |
VENKATA ET AL.: "Chemically programmed antibodies: Endothelin receptor targeting CovX-bodies", BIOORGANIC AND MEDICAL CHEMISTRY LETTERS, vol. 17, 2007, pages 501 - 506, XP008154000 * |
Also Published As
Publication number | Publication date |
---|---|
EP2480579A2 (fr) | 2012-08-01 |
CA2773978A1 (fr) | 2011-03-31 |
MX2012003514A (es) | 2012-04-19 |
IN2012DN02423A (fr) | 2015-08-21 |
EP2480579A4 (fr) | 2013-07-31 |
KR20120105429A (ko) | 2012-09-25 |
WO2011038149A2 (fr) | 2011-03-31 |
CN102725311A (zh) | 2012-10-10 |
BR112012006468A2 (pt) | 2016-08-09 |
AU2010298249A1 (en) | 2012-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009117710A3 (fr) | Procédés de traitement d'inflammations | |
WO2011038149A3 (fr) | Méthodes de traitement d'une inflammation | |
MX2022003132A (es) | Composiciones de corticoesteroides administradas oralmente. | |
WO2010065491A3 (fr) | Procédés de traitement de troubles inflammatoires | |
WO2010141417A3 (fr) | Systèmes et méthodes d'altération de la fonction du tissu du muscle lisse | |
WO2008122049A3 (fr) | Procédés et compositions pour la réduction des effets secondaires des traitements thérapeutiques | |
WO2010087964A3 (fr) | Composition pour le traitement et la prévention de l'acné, procédés de fabrication des compositions, et procédés d'utilisation associés | |
WO2009109908A8 (fr) | Procédés de traitement d'une douleur inflammatoire | |
WO2007081879A3 (fr) | Méthodes pour prévenir et traiter des métastases de cancer et des pertes osseuses associées à des métastases de cancer | |
WO2010062581A3 (fr) | Composition botanique pour une réparation cutanée optimisée et utilisations associées | |
WO2007142752A3 (fr) | Dispositifs médicaux implantables composites en biocéramique-polymère | |
MX2010006823A (es) | Metodos para el tratamiento de la gota. | |
WO2010005524A3 (fr) | Systèmes et procédés d’utilisation afférents dans le traitement des anévrismes aortiques abdominaux | |
WO2009109911A8 (fr) | Procédés de traitement d'une douleur chronique | |
WO2008057246A3 (fr) | Procédé de traitement de troubles inflammatoires | |
WO2009129246A3 (fr) | Compositions et leurs procédés de préparation et d'utilisation | |
WO2008036206A3 (fr) | Dispositifs médicaux implantables à base de composite copolymère-biocéramique | |
WO2011099832A3 (fr) | Nouveau composé de benzimidazole, son procédé de préparation et composition pharmaceutique le contenant | |
WO2008017025A3 (fr) | Thérapie combinée | |
WO2009080800A3 (fr) | Méthode pour réduire le tour de taille par l'administration de bactéries du genre bifidobacterium | |
WO2011044523A3 (fr) | Compositions et procédés destinés à traiter l'obésité | |
WO2009016488A3 (fr) | Compositions comprenant des antidépresseurs tétracycliques pour le traitement d'un cancer et procédés apparentés | |
WO2009155070A3 (fr) | Compositions et procédés pour le traitement d’inflammation et de lésions hyperkératotiques | |
WO2011031890A3 (fr) | Thérapie ciblée sur des cellules souches cancéreuses et contre un cancer pharmacorésistant | |
WO2010127197A3 (fr) | Procédé et composition de traitement d'une acidocétose diabétique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080052628.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10819481 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2773978 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010819481 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2423/DELNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012531036 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2012/003514 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010298249 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 201270349 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 2010298249 Country of ref document: AU Date of ref document: 20100923 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20127010455 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112012006468 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112012006468 Country of ref document: BR Kind code of ref document: A2 Effective date: 20120322 |